Vanderbilt Digestive Disease Center

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Primary biliary cholangitis3 trials

Phase

• Phase 22 trials
• Phase 31 trial

Status

• Completed2 trials
• Active, not recruiting1 trial

Lead sponsor

• Calliditas Therapeutics Suisse SA1 trial
• Ipsen1 trial
• Kowa Research Institute, Inc.1 trial

Running trials

• Active, not recruiting

  Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)

  NCT04526665· Phase 3· Ipsen· Source

Closed trials

• Completed

  Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment.

  NCT06247735· Phase 2· Kowa Research Institute, Inc.· Source

• Completed

  A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness

  NCT05014672· Phase 2· Calliditas Therapeutics Suisse SA· Source